NCT06565598 Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy
| NCT ID | NCT06565598 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First People's Hospital of Xiushui |
| Condition | Nonfunctional Kidney |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-05-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the effect of single-layer robot-assisted retroperitoneal approach for radical nephrectomy without tubularization
Eligibility Criteria
Inclusion Criteria: * Patients with various causes requiring radical nephrectomy Exclusion Criteria: * patients who could not tolerate laparoscopic surgery for various reasons * patients whose preoperative blood pressure and blood glucose were not controlled to normal * patients with contralateral nonfunctioning kidney or solitary kidney * Multiple organ surgery at the same time
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06565598 clinical trial?
This trial is open to participants of all sexes, studying Nonfunctional Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06565598 currently recruiting?
Yes, NCT06565598 is actively recruiting participants. Contact the research team at 416915611@qq.com for enrollment information.
Where is the NCT06565598 trial being conducted?
This trial is being conducted at Jiujiang, China.
Who is sponsoring the NCT06565598 clinical trial?
NCT06565598 is sponsored by The First People's Hospital of Xiushui. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.